InsiderTrades

Form 4 for BIO BIO-RAD LABORATORIES, INC.

Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-28 · accession 0001062993-24-004959 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-02-29 2024-02-28 BIO ERNST TIMOTHY S EVP, GC, Sec M - OptEx $326.15 +2,500 5,897 +74% +$815.4K
D 2024-02-29 2024-02-28 BIO ERNST TIMOTHY S EVP, GC, Sec S - Sale+OE $330.55 -2,500 3,397 -42% -$826.4K
D 2024-02-29 2024-02-28 BIO ERNST TIMOTHY S EVP, GC, Sec M - OptEx $0.00 -2,500 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Bio-Rad A Common Stock 2024-02-28 M A 2,500 $326.15 5,897.48 D — — (F1) Includes 13.6810 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/29/2023.
2 Common Bio-Rad A Common Stock 2024-02-28 S D 2,500 $330.55 3,397.48 D — —
3 Derivative Non-Qualified Stock Option (right to buy) 2024-02-28 M D 2,500 $0.00 0 D $326.15 · — to 2028-09-04 2,500 Bio-Rad A Common Stock (F2) The option, representing a right to purchase a total of 2,500 shares, became exercisable in five equal annual installments beginning on September 4, 2019, which was the first anniversary of the date on which the option was granted.